Meet the TARGIT IORT Surgeons
Mr Nathan Coombs
Mr Nathan Coombs is a senior consultant breast surgeon with 20 years experience. Based at Swindon’s Great Western Hospital and the Shalbourne Suite, he first became involved in IORT in November 2012 and treated the first patient in Wiltshire in 2015. He graduated from Southampton University and has worked in the NHS since 1992. He completed an 18 month fellowship at Sydney’s Breast Cancer Institute where he gained expertise in minimally invasive breast cancer techniques and researched extensively about hormone therapy and breast cancer risk.
As a trained endocrine and general surgeon, he also specialises in thyroid surgery and complex hernia operations. He is the director of The Hernia Clinic and is the main surgeon for laparoscopic (keyhole) hernia surgery in the region.
Professor Jayant Vaidya
Professor Jayant Vaidya is a breast cancer expert who specialises in the diagnosis and treatment of diseases of the breast. He is a Consultant Surgeon at the Whittington, Royal Free and University College London Hospitals.
Professor Vaidya is very active in many research projects for breast disease and breast cancer. With his PhD thesis at University College London, he pioneered the concept of targeted intraoperative radiotherapy (TARGIT or IORT), to deliver radiotherapy to women at the time of surgery as opposed to the usual three- or four-week course of post-operative radiotherapy.
Professor Vaidya qualified in surgical oncology (MBBS MS DNB) from the Bombay University and the National Board. His PhD is from London University and he is a Fellow of the Royal College of Surgeons, FRCS, UK.
Professor Michael Douek
Michael Douek is Professor of Surgical Oncology and Breast Surgeon at King’s College London and Honorary Consultant Surgeon at Guy’s and St Thomas’ Hospital. He has a research interest in developing and evaluating novel techniques for cancer surgery. Besides developing a novel magnetic technique for sentinel node biopsy and lesion localization, he is one of the pioneers of intra-operative radiotherapy for breast cancer. He is currently Chief Investigator of a number of internationl clinical trials. In 2015, he was awarded a prestigious Hunterian Professorship by the Royal College of Surgeons of England.
Michael is a Member of Council of the Association of Breast Surgery (UK), Member of Council of the British Association of Surgical Oncology / Association of Cancer Surgery (BASO/ACS) and a committee member of the British Breast Group. He is also an examiner for the European Board of Surgery examinations.